A new cellular immunotherapy to treat acute myeloid leukemia
A new cellular immunotherapy to treat acute myeloid leukemia
批准号:
325288
负责人:
Zhang Li
金额:
$13.38万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-02-01 至 2016-02-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The efforts focused on discovering new types of treatments for human diseases sometimes seemed stalled for many years before a breakthrough occurs that leads to an extended period of significant advancements. As an example, monoclonal antibodies were firs
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a platform for "off-the-shelf" CAR-T cell therapies for cancer using double negative T cells
-
批准号:401692
-
项目类别:Operating Grants
-
资助金额:$51.27万
-
财政年份:2019
-
负责人:Zhang Li
-
依托单位:
Establishing donor-specific transplantation tolerance by harnessing DN regulatory T cells
-
批准号:321192
-
项目类别:Operating Grants
-
资助金额:$49.28万
-
财政年份:2015
-
负责人:Zhang Li
-
依托单位:
Development of personalized immunotherapy to treat lung cancer using gamma-delta-T cells
-
批准号:239690
-
项目类别:Operating Grants
-
资助金额:$57.19万
-
财政年份:2011
-
负责人:Zhang Li
-
依托单位:
海外基金